Mumbai, Aug. 16 -- Alembic Pharmaceuticals (Alembic) today announced that it has received final approval from the US Food & Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA) ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback